Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.345 EUR | -1.47% | -1.88% | -15.16% |
Business Summary
Number of employees: 234
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Therapeutics
100.0
%
| 26 | 53.0 % | 18 | 100.0 % | -28.95% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
France
100.0
%
| 26 | 53.0 % | 18 | 100.0 % | -28.95% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Sourdive
FOU | Founder | 57 | 20/99/20 |
André Choulika
FOU | Founder | 59 | 20/99/20 |
Bing C. Wang
DFI | Director of Finance/CFO | 47 | 10/22/10 |
Mark Frattini
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/20/01 |
Stephan Reynier
CMP | Compliance Officer | 55 | 01/11/01 |
Chief Tech/Sci/R&D Officer | 61 | 01/01/01 | |
Arthur Stril
IRC | Investor Relations Contact | 35 | 01/18/01 |
Human Resources Officer | 54 | 16/20/16 | |
Steve Doares
PRN | Corporate Officer/Principal | - | 21/20/21 |
General Counsel | 42 | 01/08/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 75 | 05/20/05 | |
André Choulika
FOU | Founder | 59 | 20/99/20 |
David Sourdive
FOU | Founder | 57 | 20/99/20 |
Laurent Arthaud
BRD | Director/Board Member | 61 | 28/11/28 |
Pierre Bastid
BRD | Director/Board Member | 69 | 28/11/28 |
Director/Board Member | 57 | 28/22/28 | |
Donald Bergstrom
BRD | Director/Board Member | 52 | 28/22/28 |
Rainer Boehm
BRD | Director/Board Member | 63 | 29/17/29 |
Cécile Chartier
BRD | Director/Board Member | - | 27/23/27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 55,583,768 | 55,583,768 ( 100.00 %) | 0 | 100.00 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
CALYXTPAR 2.28% | 479,264 | 2.28% | 10,764,269 $ |
Company contact information
Sector
Sales per Business
Sales per region
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.16% | 180M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ALCLS Stock
- Company Cellectis S.A.